Anne Hedengran Nagstrup

Anne Hedengran Nagstrup

Senior Researcher, ph.d.

ORCID: 0000-0002-7556-4658

Publication year:
All
1 - 4 out of 4Page size: 10
  1. 2023
  2. Published

    Controversial preservation of eye drops: The toxicity of benzalkonium chloride

    Nagstrup, Anne Hedengran & Kolko, Miriam, 2023, In: Adverse Drug Reaction Bulletin. 338, 1, p. 1311-1314

    Research output: Contribution to journal › Review › Research › peer-review

  3. Published

    The molecular aspect of anti-glaucomatous eye drops: are we harming our patients?

    Nagstrup, Anne Hedengran & Kolko, Miriam, 2023, In: Molecular Aspects of Medicine. 93, 10 p., 101195.

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment

    Kolko, Miriam, Gazzard, G., Baudouin, C., Beier, S., Brignole-Baudouin, F., Cvenkel, B., Fineide, F., Nagstrup, Anne Hedengran, Hommer, A., Jespersen, E., Messmer, E. M., Murthy, R., Sullivan, A. G., Tatham, A. J., Utheim, T. P., Vittrup, M. & Sullivan, D. A., 2023, In: Ocular Surface. 29, p. 456-468

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    The use of benzalkonium chloride in topical glaucoma treatment

    Nagstrup, Anne Hedengran, 2023, In: Acta Ophthalmologica. 101, S278, p. 3-21

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 233514402